For rapid, on‑site screening in under 10 minutes, colloidal gold immunochromatographic strips are assembled as a series of functional pads laminated onto a rigid plastic backing. The core structure flows from a treated sample pad to a conjugate release pad, onto a nitrocellulose membrane carrying the critical test and control lines, and finally into a wicking absorbent pad. Functionalizing that nitrocellulose membrane requires two essential biological raw materials: a target‑carrier coating antigen dispensed at the test line and a species‑specific secondary antibody dispensed at the control line.
A colloidal gold lateral flow strip is a capillary‑driven system where every component plays a dual role: manage fluidics and participate in the immune reaction. While the nitrocellulose membrane hosts the visible readout, the true sensitivity of the strip is determined upstream — by the quality of the gold‑antibody conjugate and how the membrane’s two lines are coated. Strategic material selection and precise processing are what turn a simple piece of paper into a reliable diagnostic tool.
The Layered Structure of a Colloidal Gold Lateral Flow Strip
A rapid colloidal gold strip is not a single piece of paper. It is a engineered stack of four functional zones, each tuned to handle a specific step in the assay.
The Sample Pad: Conditioning the Sample
The sample pad is the entry point. It is pre‑treated with a formulation of PBS, BSA, sucrose, and Tween 20.
This treatment accomplishes three things simultaneously: it buffers the sample to a compatible pH, it blocks non‑specific interactions that would trap the analyte, and it ensures a smooth, even flow of liquid into the next pad.
The Conjugate Pad: Storing the Detection Engine
Immediately after the sample pad sits the conjugate pad. Here, colloidal gold‑antibody conjugates are dried and stabilized.
As the sample rehydrates this pad, the labeled antibodies become mobile and begin binding to any target analyte present. This pre‑loading of the signal generator allows the assay to run without any additional incubation or reagent addition steps.
The Nitrocellulose Membrane: The Reaction Matrix
Nitrocellulose provides the porous, high‑binding solid phase where the final immune complexes are captured. It functions as both the fluidic highway and the visualization canvas.
Its surface is functionalized with two distinct lines of biological reagents, which we will detail below. The membrane’s pore size, typically around 0.45 µm, governs the flow rate and the opportunity for interactions to occur.
The Absorbent Pad: Maintaining Capillary Drive
The final pad acts as a waste reservoir and a force pump. By wicking liquid away from the membrane’s end, it maintains the consistent capillary force that ensures the entire sample volume passes through the test and control lines without back‑flow.
Functionalizing the Nitrocellulose Membrane: The Two Critical Lines
Functionalization refers to the precise dispensing of biological reagents to create the test and control zones. Without these, the membrane is just an inert white strip.
The Test Line: Capturing the Signal
The test line is created by dispensing a target‑carrier coating antigen. For competitive immunoassays common in small‑molecule screening, this is a conjugate of the target molecule linked to a larger carrier protein (e.g., BSA).
When a sample is negative, free gold‑labeled antibodies will bind here, creating a visible pink line. When the sample is positive, the target analyte in the solution occupies these antibodies, preventing them from binding to the test line and causing it to disappear. A typical coating concentration is 0.5 mg/mL, though this must be optimized for each assay.
The Control Line: Validating the Assay
The control line is coated with a species‑specific secondary antibody, such as goat anti‑mouse IgG at 1.0 mg/mL. This antibody recognizes and binds the gold‑labeled primary antibody regardless of whether the target analyte is present.
Its role is purely confirmatory. A visible line here proves that the conjugate was functional, the sample flowed correctly, and the capillary forces worked as designed. Without a control line, the test result is invalid.
The Hidden Driver: The Colloidal Gold Conjugate
The quality of the colloidal gold conjugate is what translates a good monoclonal antibody into a sensitive test line. The raw materials and preparation method for the conjugate are as important as the membrane coatings.
Gold Nanoparticle Specifications
Spherical gold nanoparticles with a diameter of ~30 nm are the standard choice. This size offers the best balance between a visually intense pink color and physical stability.
Uniform ellipticity (near 1.1) is critical; irregular particles aggregate unpredictably and cause patchy release from the conjugate pad.
Conjugation Chemistry and Stabilization
Antibody adsorption to gold is electrostatic. The labeling system’s pH must be adjusted to alkaline conditions, often pH 9.0 using sodium carbonate, to bring the antibody near its isoelectric point and facilitate passive adsorption.
After conjugation, the nanoparticles require two final treatments: 1% bovine serum albumin (BSA), which blocks any remaining protein‑binding sites on the gold surface, and 1% sucrose, which stabilizes the conjugate during drying on the pad. Without these, the conjugate will aggregate irreversibly and lose all reactivity.
Understanding the Trade-offs in Material Selection
No single formulation fits all tests. Every choice involves a trade‑off that the developer must navigate.
- Gold nanoparticle size: Larger particles give a stronger visual signal per bound event but are less stable and can cause steric hindrance. Smaller particles flow faster but produce a fainter line. The ~30 nm standard is a compromise that works for most on‑site screening applications, but a different diameter may be required for ultra‑low detection limits.
- Antibody coating density: Coating the membrane with a high antigen concentration ensures a strong signal for negative samples but can raise the detection cut‑off, making the test less sensitive. Lower concentrations increase sensitivity but risk a weak or inconsistent control line. Optimization must align with the target regulatory cutoff.
- Sample pad treatments: Over‑blocking with BSA can slow release and reduce signal. Under‑blocking leads to non‑specific binding and false positives. The exact balance of surfactants, proteins, and sugars must be re‑adjusted for each new sample matrix, such as cucumber extract versus apple extract.
Making the Right Choice for Your Diagnostic Goal
The best raw materials and strip architecture depend entirely on the intended use case.
- If your primary focus is ultra‑high sensitivity (low ng/mL detection): Prioritize high‑affinity monoclonal antibodies and invest time in optimizing gold nanoparticle diameter and pH for maximum conjugation efficiency. The test‑line coating concentration will likely be a critical iterative variable.
- If your primary focus is robust, cost‑effective field screening: Standardize 30 nm gold nanoparticles and strict quality control on pad treatments. Use BSA and sucrose stabilization protocols religiously, as batch‑to‑batch reproducibility in the conjugate pad is often the leading cause of field failure.
- If your primary focus is a consistent visual readout across varying sample types: Look beyond the membrane to the sample pad chemistry. A balanced surfactant and blocking buffer system will minimize matrix effects and ensure reliable membrane functionalization delivers a clean, interpretable line every time.
Every successful strip is a system. The answer is never in one component alone, but in how the sample pad, conjugate, membrane coatings, and absorbent pad work as one seamless fluidic and immunological unit.
Summary Table:
| Component / Zone | Primary Function | Essential Raw Materials & Specifications |
|---|---|---|
| Sample Pad | Buffers sample, prevents non-specific binding, ensures flow | PBS, BSA, Sucrose, Tween 20 |
| Conjugate Pad | Stores and releases target detection engine | ~30 nm Gold Nanoparticles, Antibodies, 1% BSA, 1% Sucrose |
| NC Membrane (Test Line) | Captures target analyte to form signal line | Target-carrier coating antigen (e.g., BSA conjugate ~0.5 mg/mL) |
| NC Membrane (Control Line) | Validates fluid flow and conjugate functionality | Species-specific secondary antibody (e.g., Goat anti-Mouse IgG ~1.0 mg/mL) |
| Absorbent Pad | Maintains capillary force and collects liquid waste | High-wicking cellulosic absorbent matrix |
Accelerate Your Lateral Flow Assay Development with CamelBio
Transitioning from assay concept to high-performing commercial diagnostic test requires reliable raw materials and precise technical execution. CamelBio provides diagnostic manufacturers, labs, and research institutes with one-stop access to IVD raw materials, technical services, and expert consulting—covering every stage from concept to clinic.
Whether you need ultra-pure gold nanoparticles, high-affinity antibodies, or customized membrane functionalization protocols, our diagnostic experts are here to elevate your strip performance and reproducibility.
Contact Us Today to request raw material samples or explore our technical consulting services!